NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000019224

Registered date:03/10/2015

A clinical evaluation of safety of combination therapy with Rapid Onset Opioid and Short Acting Opioid.

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedCancer Pain
Date of first enrollment2015/04/01
Target sample size30
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Breakthrough pain was managed with fentanyl buccal tablet and short-acting opioid. Breakthrough pain was managed with sublingual fentanyl and short-acting opioid.

Outcome(s)

Primary OutcomeAnalgesic effects (NRS, STAS-J) Adverse effect rate
Secondary OutcomeEfficacy rate

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1. the hypersensitiveness to opioids 2. serious respiratory depression or serious chronic obstructive pulmonary disease 3. disturbance of consciousness or the lack of judgment ability 4. gastrointestinal obstruction 5. not applicable determined by the attending physician responsible for the trial.

Related Information

Contact

public contact
Name Motonao Kurahashi
Address 2-1-7, Fukushima, Fukushima-ku, Osaka City, Osaka, 553-0003 Japan Japan
Telephone 06-6458-5821
E-mail kurahashi.motonao@c3.kepco.co.jp
Affiliation Kansai Electric Power Hospital Department of Pharmacy
scientific contact
Name Toru Kajiyama
Address 2-1-7, Fukushima, Fukushima-ku, Osaka City, Osaka, 553-0003 Japan Japan
Telephone 06-6458-5821
E-mail mtkaji@live.jp
Affiliation Kansai Electric Power Hospital Department of Palliative Medicine